GH Research PLC will present data from its Phase 2a clinical trial of inhaled Mebufotenin at the ISBD Annual Meeting in Chiba, Japan, scheduled for September 17-19, 2025.
AI Assistant
GH RESEARCH PLC
2025
6 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.